COMPARISON OF EFFICACY OF TWO DIFFERENT DOSES OF DEXMEDETOMIDINE ON THE HAEMODYNAMIC PARAMETERS OF PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY:A PROSPECTIVE RANDOMIZED DOUBLE-BLIND STUDY

Main Article Content

Dr Deependar Kumar Adarshi
Dr Ajeet Kumar Dev
Dr Adnan Naim

Keywords

Dexmedetomidine, Pneumoperitoneum, Cholecystectomy, Analgesia

Abstract

To compare the effects of two different doses of Dexmedetomidine infusion (0.3μg/kg/hour and 0.6μg/kg/hour) on hemodynamic parameters (SBP, DBP, MAP, HR and SPO2) during Laryngoscopy, intubation and pneumoperitoneum in patients undergoing laparoscopic cholecystectomy


Material and Methods: This prospective, randomized, double-blind study was conducted in the Department of Anaesthesia at a tertiary care hospital over one and a half years following approval from the Institutional Ethics Committee with sample size of 70 (35 in each group).


Results: Group 2 demonstrated significantly better intraoperative hemodynamic stability. This included lower and more consistent HR and SBP, especially during key stress-inducing events such as intubation, pneumoperitoneum. Postoperatively, Group 2 maintained superior hemodynamic stability, with lower HR and SBP over a 24-hour period compared to Group 1. Group 2 exhibited higher sedation scores immediately postoperatively, but sedation levels became comparable between groups within 4 hours.Patients in Group 2 reported significantly lower VAS scores, indicating better pain control. Group 2 experienced a higher incidence of adverse events, notably bradycardia (22.9% vs. 8.6%) and hypotension (20.0% vs. 5.7%)


Conclusion: The results demonstrate that a higher dose of dexmedetomidine (0.6 µg/kg/h) provides better intraoperative and postoperative hemodynamic stability, superior analgesia, and effective sedation compared to a lower dose (0.3 µg/kg/h). However, the increased incidence of bradycardia and hypotension in the higher dose group necessitates vigilant monitoring and appropriate management.

Abstract 0 | Pdf Downloads 0

References

1. Duca, O. Bãlã, N. Al Hajjar Laparoscopic cholecystectomy: incidents and complications. A retrospective analysis of 9542 consecutive laparoscopic operations, HPB,Volume 5, Issue 3,200;5(3):152-8. Kapoor T, Wrenn SM, Callas PW, Abu-Jaish W. Cost Analysis and Supply Utilization of Laparoscopic Cholecystectomy. Minim Invasive Surg. 2018;2018:7838103.
2. Strasberg SM. Tokyo Guidelines for the Diagnosis of Acute Cholecystitis. J Am Coll Surg. 2018 Dec;227(6):624.
3. Koivusalo AM, Lindgren L. Effects of carbon dioxide pneumoperitoneum for laparoscopic cholecystectomy. Acta Anaesthesiol Scand. 2000 Aug;44(7):834-41.
4. Naude GP, Bongard FS. Helium insufflation in laparoscopic surgery. Endosc Surg Allied Technol. 1995 Aug;3(4):183-6
5. Shakya R, Maharjan S. Effects of Intravenous Dexmedetomidine on Hemodynamic Responses to Pneumoperitoneum During Laparoscopic Cholecystectomy. Asian J Anesthesiol. 2023.
6. Masoori TA, Gupta K, Agarwal S, Bansal M, Zuberi A, Samad A. Clinical efficacy of dexmedetomidine in two different doses to attenuate the hemodynamic changes during laparoscopic cholecystectomy. Int J Res Med Sci. 2018;6:959.
7. Gautam S, Prakash V, Mishra N, Prakash R, Kumar S, Jafa S. Effect of Two Different Doses of Dexmedetomidine on the Hemodynamics of “Hypertensive
8. Patients” Undergoing Laparoscopic Cholecystectomy. Anesth Essays Res. 2020;14:401-5.
9. Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001 Jan;14(1):13-21
10. Vora, Kalpana S.; Baranda, Ushma; Shah, Veena R.; Modi, Manisha; Parikh, Geeta P.1; Butala, Bina P.1. The effects of dexmedetomidine on attenuation of hemodynamic changes and there effects as adjuvant in anesthesia duringlaparoscopic surgeries.Saudi Journal of Anaesthesia9(4):p386-392,Oct–Dec2015.
11. Tamsen A, Gordh T. Epidural clonidine produces analgesia. Lancet. 1984;2:231–232. doi: 10.1016/s0140-6736(84)90523-3
12. Alquist RP. A study of adrenergic receptors. Am J Physiol. 1948;153:586–589 Langer SZ. Presynaptic regulation of catecholamine release. Biochem Pharmacol. 1974;23:1793–1800
13. Langer SZ. Presynaptic regulation of catecholamine release. Biochem
a. Pharmacol. 1974;23:1793–1800
14. Drew GM, Whiting SB. Evidence for two distinct types of postsynaptic alphaadrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol. 1979;67:207– 215
15. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of dexmedetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988;150:9–14
16. Housmans PR. Effects of dexmedetomidine on contractility, relaxation, and intracellular calcium transients of isolated ventricular myocardium. Anesthesiology. 1990;73:919–922
17. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992;77:1134–1142
18. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699–705
19. Jaakola ML, Salonen M, Lehtinen R, Scheinin H. The analgesic action of dexmedetomidine—a novel alpha 2-adrenoceptor agonist—in healthy volunteers. Pain. 1991;46:281–285
20. Aantaa R, Kanto J, Scheinin M. Intramuscular dexmedetomidine, a novel alpha 2-adrenoceptor agonist, as premedication for minor gynaecological surgery. Acta Anaesthesiol Scand. 1991;35:283–288

21. Taittonen MT, Kirvela OA, Aantaa R, Kanto JH. Effect of clonidine and dexmedetomidine premedication on perioperative oxygen consumption and haemodynamic state. Br J Anaesth. 1997;78:400–40
22. Aantaa R, Jaakola ML, Kallio A, Kanto J. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology. 1997;86:1055–1060
23. Bührer M, Mappes A, Lauber R, Stanski DR, Maitre PO. Dexmedetomidine decreases thiopental dose requirement and alters distribution pharmacokinetics. Anesthesiology. 1994;80:1216–1227
24. Kharasch ED, Hill HF, Eddy AC. Influence of dexmedetomidine and clonidine on human liver microsomal alfentanil metabolism. Anesthesiology. 1991;75:520–5
25. Dr. PG Raghavendra and Dr. Chandana et al. MH International Journal of Medical Anesthesiology 2020; 3(3): 56-59.
26. Dongare SR, Deshpande SB, Rathi BP. Comparative study of intraoperative hemodynamic effects of dexmedetomidine and saline during laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol. 2021;37(4):496-501
27. Chrysostomou C, Schmitt CG. Dexmedetomidine: sedation, analgesia and beyond. Expert Opin Drug Metab Toxicol. 2008; 4:619-27.
28. Poonam Ghodki S, Shalini Thombre K, Shalini Sardesai P, Kalpana Harnagle D. Dexmedetomidine as an anesthetic adjuvant in laparoscopic surgery: An observational study using entropy monitoring. J Anaesthesiol Clin Pharmacol. 2012; 28:334-338.
29. Abu-Halaweh SA, Al Oweidi AK, Abu-Malooh H, Zabalawi M, Alkazaleh F, Abu-Ali H et al. Intravenous dexmedetomidine infusion for labour analgesia in patient with preeclampsia. Eur. J Anaesthesiol. 2009; 26:86-7.
30. Palanisamy A, Klickovich RJ, Ramsay M, Ouyang DW, Tsen LC. Intravenous dexmedetomidine as an adjunct for labor analgesia and cesarean delivery anesthesia in a parturient with a tethered spinal cord. Int. J Obstet Anesth. 2009;18:258-61
31. Lawrence CJ, De Lange S. Effects of a single preoperative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia. 1997; 52(8):736-44.
32. Tufanogullari B, White PF, Peixoto MP, Kianpour D, Lacour T, Griffin J. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg. 2008; 106:1741-8.
33. Manne GR, Upadhyay M, Swadia V. Effects of low dose dexmedetomidine infusion on haemodynamic stress response, sedation and post-operative analgesia requirement in patients undergoing laparoscopic cholecystectomy. Indian J Anaesth. 2014;58:726-31.
34. Ye Q, Wang F, Xu H, Wu L, Gao X. Effects of dexmedetomidine on intraoperative hemodynamics, recovery profile and postoperative pain in patients undergoing laparoscopic cholecystectomy: a randomized controlled trial. BMC Anesthesiol. 2021 Mar 1;21(1):63
35. Kaye AD, Chernobylsky DJ, Thakur P, Siddaiah H, Kaye RJ, Eng LK, Harbell MW, Lajaunie J, Cornett EM. Dexmedetomidine in Enhanced Recovery After Surgery (ERAS) Protocols for Postoperative Pain. Curr Pain Headache Rep. 2020 Apr 2;24(5):21
36. Gupta K, Bansal P, Gupta PK, Singh A. "Dexmedetomidine as an anesthetic adjuvant in laparoscopic cholecystectomy: A randomized double-blind controlled study." Saudi J Anaesth. 2015;9(4):386-390.
37. Talke P, Chen R, Thomas B, Aggarwall A, Gottlieb A, Thorborg P, Heard S, Cheung A, Son SL, Kallio A. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000 Apr;90(4):834-9.
38. Menda F, Köner O, Sayin M, Türe H, Imer P, Aykaç B. Dexmedetomidine as an adjunct to anesthetic induction to attenuate hemodynamic response to endotracheal intubation in patients undergoing fast-track CABG. Ann Card Anaesth. 2010 Jan-Apr;13(1):16-21.
39. Shi Q, Huang Q, Zhang T, Yu Y. Effects of continuous dexmedetomidine infusion on perioperative hemodynamics and stress response in laparoscopic surgeries. J Clin Anesth. 2020;61:109622.
40. Kapoor R, Dua S, Saxena AK, Narayan S. Evaluation of the Efficacy of Intraperitoneal Instillation of Ropivacaine with Dexmedetomidine Versus Ropivacaine with Ketamine for Post Operative Pain Relief following Laparoscopic Cholecystectomy: A Randomized Controlled Study. Arch Anesth Crit Care. 2023;9(5).